Augustus John Rush
#25,356
Most Influential Person Now
American Singaporean psychiatrist
Augustus John Rush's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Augustus John Rush Influential?
(Suggest an Edit or Addition)According to Wikipedia, Augustus John Rush is an internationally renowned psychiatrist. He is a professor emeritus in Duke-NUS Medical School at the National University of Singapore , and adjunct professor of psychiatry and behavioral sciences at Duke University School of Medicine. He has authored and edited more than 10 books, and over 600 scientific journal articles that are largely focused on the diagnosis and treatment of depressive and bipolar disorders.
Augustus John Rush's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). (2003) (7777)
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. (2006) (3196)
- The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression (2003) (2905)
- Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. (2006) (2419)
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006) (1928)
- The Inventory of Depressive Symptomatology (IDS): psychometric properties (1996) (1906)
- Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. (1991) (1896)
- A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. (1997) (956)
- Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. (2006) (951)
- Medication augmentation after the failure of SSRIs for depression. (2006) (940)
- Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. (2004) (933)
- The inventory for depressive symptomatology (IDS): Preliminary findings (1986) (869)
- The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation (2004) (847)
- Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania (1994) (811)
- Handbook of Psychiatric Measures (2000) (792)
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (2003) (740)
- Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. (2008) (739)
- Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. (2001) (703)
- When at first you don't succeed: sequential strategies for antidepressant nonresponders. (1997) (690)
- Estimating Individualized Treatment Rules Using Outcome Weighted Learning (2012) (600)
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. (1994) (599)
- Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006) (593)
- The STAR*D project results: A comprehensive review of findings (2007) (567)
- Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study∗ ∗ See accompanying Editorial, in this issue. (2000) (551)
- Antidepressant Actions of Histone Deacetylase Inhibitors (2009) (547)
- Remissions in Maternal Depression and Child Psychopathology: A STAR*D-Child Report (2006) (539)
- Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. (2003) (535)
- Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial (2005) (517)
- The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. (2001) (511)
- Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome (2001) (494)
- Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. (1998) (476)
- ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses (2010) (457)
- What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. (2009) (437)
- Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. (2006) (437)
- Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. (2003) (413)
- ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE (2001) (412)
- Effect of age at onset on the course of major depressive disorder. (2007) (410)
- Methods to improve diagnostic accuracy in a community mental health setting. (2000) (403)
- A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. (2006) (399)
- Vagus nerve stimulation: a new tool for brain research and therapy∗ (2000) (392)
- Gender differences in depression: findings from the STAR*D study. (2005) (385)
- Implementing evidence-based practices for persons with severe mental illnesses. (2001) (380)
- Onset and persistence of postpartum depression in an inner-city maternal health clinic system. (2001) (374)
- An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report (2006) (359)
- The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms (2000) (359)
- Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report (2009) (358)
- Hippocampal Remodeling and Damage by Corticosteroids: Implications for Mood Disorders (1999) (350)
- Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. (2005) (349)
- Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. (2004) (343)
- Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. (1981) (341)
- The impact of treatment-resistant depression on health care utilization and costs. (2002) (338)
- Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study (2005) (330)
- The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. (1998) (328)
- Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. (2006) (327)
- STAR*D: what have we learned? (2007) (324)
- A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression (2005) (323)
- Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. (2011) (322)
- Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. (2007) (320)
- Comprehensive Guide to Interpersonal Psychotherapy (2002) (317)
- Cognitive patterns in symptomatic and remitted unipolar major depression. (1984) (315)
- Vagus nerve stimulation is associated with mood improvements in epilepsy patients (2000) (308)
- Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients (1977) (302)
- Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D (2004) (301)
- A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. (2009) (297)
- Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. (2000) (297)
- Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. (2004) (291)
- A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. (2006) (291)
- The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. (2007) (287)
- Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? (2005) (278)
- The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. (1999) (269)
- Early physical and sexual abuse associated with an adverse course of bipolar illness (2002) (266)
- Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy (2004) (266)
- Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes (2002) (265)
- A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. (1994) (264)
- Sertraline as a first‐line treatment for cholestatic pruritus (2007) (258)
- Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. (2005) (256)
- The FKBP5-Gene in Depression and Treatment Response—an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort (2008) (255)
- Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. (1999) (254)
- Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. (1981) (248)
- 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. (2005) (237)
- Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. (2005) (237)
- Melancholic symptom features and DSM-IV. (1994) (237)
- MAOIs in the Contemporary Treatment of Depression (1995) (237)
- Treatment of major depression (1993) (236)
- Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects (2006) (235)
- Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. (2005) (233)
- The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. (2001) (233)
- 2016 in Review. (2016) (222)
- High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure (2002) (221)
- Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination (2002) (214)
- Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder (1998) (210)
- Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. (2007) (208)
- Workplace performance effects from chronic depression and its treatment. (1998) (208)
- Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. (2008) (202)
- Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. (2010) (202)
- Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. (2007) (202)
- Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. (1999) (199)
- Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. (2010) (197)
- Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. (2003) (193)
- Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. (1998) (192)
- Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. (2006) (192)
- The varied clinical presentations of major depressive disorder. (2007) (192)
- Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. (1982) (191)
- Acupuncture: a promising treatment for depression during pregnancy. (2004) (191)
- The Montgomery Äsberg and the Hamilton ratings of depression: A comparison of measures (2006) (190)
- Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. (2008) (190)
- The STAR*D study: treating depression in the real world. (2008) (186)
- Research issues in the study of difficult-to-treat depression (2003) (185)
- Polysomnographic findings in recently drug-free and clinically remitted depressed patients. (1986) (184)
- The Epidemiology of Major Depressive Disorder (2009) (184)
- Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. (2005) (184)
- Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. (2005) (183)
- A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia (2005) (181)
- Prevalence of major depressive episode in CKD. (2009) (174)
- Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. (2009) (173)
- Factors associated with chronic depressive episodes: a preliminary report from the STAR‐D project (2005) (172)
- The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. (2001) (172)
- The dexamethasone suppression test in patients with mood disorders. (1996) (171)
- Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. (2008) (170)
- Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study. (2011) (170)
- The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. (1998) (169)
- Dropouts versus completers among chronically depressed outpatients. (2007) (168)
- The Importance of Irritability as a Symptom of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (2009) (168)
- The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder (2008) (168)
- Validation of the prospective NIMH-Life-Chart Method (NIMH-LCMTM-p) for longitudinal assessment of bipolar illness (2000) (164)
- Improving the Prediction of Treatment Response in Depression: Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures (2008) (163)
- A descriptive analysis of minor depression. (2002) (162)
- International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol (2011) (160)
- Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication (2011) (159)
- Relationship between objective and subjective sleep measures in depressed patients and healthy controls (1997) (159)
- What Clinical and Symptom Features and Comorbid Disorders Characterize Outpatients with Anxious Major Depressive Disorder: A Replication and Extension (2006) (157)
- Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. (2008) (154)
- Depression and chronic low back pain: establishing priorities in treatment. (2000) (154)
- Children of currently depressed mothers: a STAR*D ancillary study. (2006) (154)
- The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. (2001) (153)
- Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. (2006) (152)
- Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. (2015) (151)
- Health-related quality of life in depression: a STAR*D report. (2010) (148)
- Strengthening clinical effectiveness trials: Equipoise-stratified randomization (2001) (147)
- Relation of serum valproate concentration to response in mania. (1996) (147)
- Sex differences in response to citalopram: a STAR*D report. (2009) (146)
- Cognitive‐behavioral group therapy for bulimia (1986) (145)
- Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls (2000) (144)
- Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care (2007) (144)
- Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. (2007) (144)
- Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. (2007) (143)
- Reduced rapid eye movement latency. A predictor of recurrence in depression. (1987) (143)
- Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: A Literature Review and a Proposal for a Novel Approach to Improve Practice (2006) (142)
- Cognitive-behavioral therapy for bipolar disorder. (1996) (140)
- Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial (2017) (139)
- Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. (2002) (138)
- Comparison of the effects of cognitive therapy and pharmacotherapy on hopelessness and self-concept. (1982) (137)
- Benzodiazepines as antidepressants: Does GABA play a role in depression? (1995) (137)
- The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. (1999) (136)
- Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. (2004) (136)
- Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. (2005) (135)
- CYP2C19 variation and citalopram response (2011) (134)
- SLC6A4 variation and citalopram response (2009) (134)
- Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. (2009) (133)
- Genome-wide association study of suicide attempts in mood disorder patients. (2010) (132)
- Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients (2005) (132)
- Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. (2010) (132)
- Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. (2001) (131)
- The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. (1999) (130)
- Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation. (2000) (130)
- Flexible treatment strategies in chronic disease: clinical and research implications (2000) (129)
- Algorithms and Collaborative-care Systems for Depression: Are They Effective and Why? A Systematic Review (2006) (128)
- Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. (2007) (128)
- Measurement-based care in psychiatric practice: a policy framework for implementation. (2011) (127)
- Insomnia in Patients With Depression: A STAR*D Report (2010) (125)
- Cognitive biases and depression. (1989) (125)
- A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression (2013) (123)
- Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. (2015) (122)
- Strategies and tactics in the treatment of chronic depression. (1997) (121)
- Use of Bupropion in Combination with Serotonin Reuptake Inhibitors (2006) (121)
- Depression, IV: STAR*D treatment trial for depression. (2003) (120)
- Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. (2007) (120)
- Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. (2004) (120)
- Validation of depression screening scales in patients with CKD. (2009) (119)
- Recurrence of major depressive disorder in hospitalized children and adolescents. (1997) (119)
- Obsessive compulsive symptoms in schizophrenia: Frequency and clinical features (2005) (117)
- The cost consequences of treatment-resistant depression. (2004) (116)
- Factors that differentiate early vs. later onset of major depression disorder (2004) (116)
- Children with major depression show reduced rapid eye movement latencies. (1990) (116)
- Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure? (2005) (113)
- The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. (2015) (112)
- National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. (2002) (112)
- Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. (1998) (112)
- Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. (2003) (112)
- Low Plasma GABA Is a Trait-Like Marker for Bipolar Illness (1993) (112)
- Which depressions respond to placebo? (1986) (111)
- Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. (2006) (111)
- Methodological Challenges in Constructing Effective Treatment Sequences for Chronic Psychiatric Disorders (2007) (110)
- The Stanley Foundation Bipolar Network (2001) (110)
- Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. (2006) (110)
- Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. (1999) (110)
- Clinical and demographic factors associated with DSM-IV melancholic depression. (2006) (110)
- Cerebral blood flow changes during sodium-lactate-induced panic attacks. (1988) (109)
- Symptom features of postpartum depression: are they distinct? (2008) (108)
- Course and Severity of Maternal Depression: Associations with Family Functioning and Child Adjustment (2008) (108)
- Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: A preliminary report (1991) (108)
- Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept (2011) (108)
- Durability of antidepressant response to vagus nerve stimulation (VNS). (2007) (106)
- Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients (2009) (105)
- Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. (2010) (105)
- Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. (2011) (105)
- Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents (2010) (105)
- Implementing practice guidelines for depression: applying a new framework to an old problem. (2002) (104)
- Kognitive Therapie der Depression (2010) (104)
- Reduced REM latency predicts response to tricyclic medication in depressed outpatients (1989) (104)
- Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis (2007) (103)
- Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D (2008) (102)
- A controlled study of cellular immune function in affective disorders before and during somatic therapy (1985) (102)
- Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. (2008) (101)
- Increase in work productivity of depressed individuals with improvement in depressive symptom severity. (2013) (100)
- Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study (2017) (99)
- Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant Response: Association of TREK1 and Treatment Resistance in the STAR*D Study (2008) (99)
- Best clinical practice: guidelines for managing major depression in primary medical care. (1999) (98)
- A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. (1997) (98)
- Low plasma γ-aminobutyric acid levels in male patients with depression (1992) (98)
- A cognitive investigation of schizophrenic delusions. (1979) (96)
- Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. (2006) (96)
- The Effects of Nefazodone on Sleep Architecture in Depression (1994) (95)
- The identification, assessment and management of difficult-to-treat depression: An international consensus statement. (2020) (95)
- Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. (2003) (93)
- Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder (2009) (93)
- One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies (2004) (92)
- A Cognitive–Emotional Biomarker for Predicting Remission with Antidepressant Medications: A Report from the iSPOT-D Trial (2015) (92)
- Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder (2001) (91)
- 2017 in Review. (2017) (89)
- Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. (2009) (89)
- Toward a generalizable model of symptoms in major depressive disorder (1998) (89)
- Consensus guidelines in the treatment of major depressive disorder. (1998) (89)
- Customizing treatment to the patient: adaptive treatment strategies. (2007) (88)
- The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. (2003) (88)
- Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. (1988) (88)
- Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report (2009) (88)
- Bulimia and depression. (1985) (88)
- Remissions in Maternal Depression and Child Psychopathology (2013) (88)
- STAR*D (2009) (88)
- Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. (1981) (87)
- Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. (1998) (87)
- Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients (2009) (86)
- Limitations in efficacy of antidepressant monotherapy. (2007) (86)
- Pain in depression: STAR*D study findings. (2007) (86)
- Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. (2000) (85)
- Cognitive therapy of depression and suicide. (1978) (85)
- Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial (2017) (85)
- A Randomized Trial of Citalopram versus Placebo in Outpatients with Asthma and Major Depressive Disorder: A Proof of Concept Study (2005) (85)
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2008) (85)
- Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. (1996) (85)
- Polysomnographic parameters in first-degree relatives of unipolar probands (1989) (84)
- Vagus nerve stimulation. A potential therapy for resistant depression? (2000) (84)
- 2018 in Review. (2018) (84)
- A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. (2005) (84)
- Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. (1995) (84)
- Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder. (2001) (82)
- The Texas medication algorithm project: clinical results for schizophrenia. (2004) (82)
- Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders (2000) (81)
- Depression in Asthma: Prevalence and Clinical Implications. (2000) (80)
- Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. (2005) (79)
- Psychiatric Symptomatology and Disorders in Caregivers of Children With Asthma (2006) (79)
- Bupropion and Naltrexone in Methamphetamine Use Disorder. (2021) (79)
- Pharmacogenetics studies in STAR*D: strengths, limitations, and results. (2009) (77)
- A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. (2009) (76)
- A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. (2005) (76)
- Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. (2002) (76)
- High Frequency EEG Activity during Sleep: Characteristics in Schizophrenia and Depression (2005) (76)
- Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. (2004) (76)
- Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression (1997) (76)
- Cocaine and Amphetamine Use in Patients With Psychiatric Illness: A Randomized Trial of Typical Antipsychotic Continuation or Discontinuation (2003) (75)
- Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. (2001) (75)
- Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression (2003) (75)
- Remission of Maternal Depression: Relations to Family Functioning and Youth Internalizing and Externalizing Symptoms (2008) (75)
- Age-related characteristics of depression: a preliminary STAR*D report. (2005) (74)
- Sleep EEG features of adolescents with major depression (1994) (74)
- Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder (2014) (73)
- Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. (2010) (73)
- Depressive Symptoms by Self-Report in Adolescence: Phase I of the Development of a Questionnaire for Depression by Self-Report (1990) (73)
- Weight change in depression (1986) (73)
- Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. (2005) (73)
- Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo (2013) (73)
- Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression (2005) (73)
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. (2013) (73)
- What Did STAR✫D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression (2012) (73)
- Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. (2007) (71)
- Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression (2007) (70)
- Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. (2008) (70)
- Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. (2007) (70)
- Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? (2001) (69)
- The inventory of depressive symptomatology (IDS) (1996) (68)
- Delta sleep EEG in depressed adolescent females and healthy controls. (2001) (68)
- An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder (2006) (68)
- Tridimensional personality questionnaire and serotonin in bulimia nervosa (1993) (68)
- Dream recall and major depression: A preliminary report. (1995) (65)
- Digital period analysis of sleep EEG in depression (1992) (65)
- Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression (1999) (65)
- Preadult onset vs. adult onset of major depressive disorder: a replication study (2007) (64)
- Compliance With Pharmacotherapy in Mood Disorders (1995) (63)
- Sertraline versus imipramine to prevent relapse in chronic depression. (2001) (63)
- Is there a role for continuation phase cognitive therapy for depressed outpatients? (1998) (63)
- Tiagabine in treatment refractory bipolar disorder: a clinical case series. (2002) (63)
- Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. (2002) (63)
- Clinical predictors of recurrence in depression. (1989) (62)
- The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. (1999) (62)
- Plasma GABA in mood disorders. (1990) (62)
- The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. (1998) (62)
- Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. (2007) (61)
- Treating Depression to Remission (1995) (61)
- Therapist Variables That Predict Symptom Change in Psychotherapy With Chronically Depressed Outpatients. (2004) (61)
- Clinical practice guidelines. Good news, bad news, or no news? (1993) (61)
- Ethnicity/Race and Outcome in the Treatment of Depression: Results From STAR*D (2007) (60)
- Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. (2006) (60)
- Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project (2005) (60)
- Do atypical features affect outcome in depressed outpatients treated with citalopram? (2010) (60)
- Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. (2006) (59)
- Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms (1999) (59)
- Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? (1996) (59)
- Folate and unipolar depression. (2008) (58)
- On the psychometric validity of the domains of the PDSQ: an illustration of the bi-factor item response theory model. (2009) (58)
- Cognitive and behavior therapy in chronic depression (1975) (58)
- Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial (2012) (58)
- The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women (2010) (58)
- Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report (2011) (58)
- The Effects of Fluoxetine on the Polysomnogram of Depressed Outpatients: A Pilot Study (1994) (57)
- Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. (2007) (57)
- Association of Depressive Symptoms with Hippocampal Volume in 1936 Adults (2014) (57)
- Clinical characteristics of outpatients with chronic major depression. (1995) (57)
- Unwanted Events and Side Effects in Cognitive Behavior Therapy (2018) (57)
- Toward an understanding of bipolar disorder and its origin. (2003) (57)
- Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. (2003) (56)
- Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. (2002) (56)
- Efficacy of treatments for major depression. (1993) (56)
- Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. (2008) (56)
- Algorithms for optimizing the treatment of depression: making the right decision at the right time. (2003) (56)
- Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication (2019) (56)
- Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents (2000) (56)
- Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression. (2016) (55)
- The Texas Medication Algorithm Project (2004) (55)
- The Stanley Foundation Bipolar Network (2001) (55)
- A cognitive model of anxiety formation and anxiety resolution. (1985) (55)
- Constructing evidence-based treatment strategies using methods from computer science. (2007) (55)
- Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline (2001) (54)
- Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression (2018) (54)
- A comparison of self-reported versus clinician-rated symptoms in depression (1987) (54)
- Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine (2006) (54)
- Cognitive approaches to depression and suicide. (1978) (53)
- The role of psychotherapy in the treatment of depression: review of two practice guidelines. (1996) (53)
- Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. (2011) (53)
- The Relationship between Serum Prolactin Level and Sexual Functioning among Male Outpatients with Schizophrenia or Schizoaffective Disorder: A Randomized Double-Blind Trial of Risperidone vs. Quetiapine (2007) (53)
- Psychotherapies for Depressive Disorders: A Review (2001) (52)
- Perception of social interactions in depressed psychiatric patients. (1982) (52)
- Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. (2007) (52)
- Sleep parameters in bipolar I, bipolar II, and unipolar depressions (1986) (52)
- Alprazolam vs amitriptyline in depressions with reduced REM latencies. (1985) (51)
- Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. (2011) (51)
- Clinical issues in considering vagus nerve stimulation for treatment-resistant depression (2009) (51)
- Substance use among patients with a psychotic disorder in a psychiatric emergency room. (1997) (50)
- Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. (2010) (50)
- DSM Melancholic Features Are Unreliable Predictors of ECT Response: A CORE Publication (2007) (50)
- Acceptability of second-step treatments to depressed outpatients: a STAR*D report. (2007) (50)
- The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis (2019) (50)
- Clinical Management of Insomnia Disorder (2017) (50)
- Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. (2001) (50)
- Paroxetine as a treatment for premenstrual dysphoric disorder (1996) (50)
- Short-term psychotherapy of depressive disorders: current status and future directions. (1994) (50)
- Income and attrition in the treatment of depression: a STAR*D report (2009) (49)
- The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report. (2003) (49)
- Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? (2003) (49)
- Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. (2003) (49)
- A pilot study of the treatment of outpatients with chronic pain: Symptom control, stimulus control and social system intervention (1978) (49)
- Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. (2018) (48)
- Sex differences in the distribution of EEG frequencies during sleep: unipolar depressed outpatients. (1995) (48)
- Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: A replication and extension (1987) (48)
- Redefining the role of psychiatry in medicine. (1996) (48)
- Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. (2016) (48)
- Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication (2003) (48)
- Difficult-to-treat depression: A clinical and research roadmap for when remission is elusive (2018) (48)
- Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D). (2004) (47)
- Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. (2011) (47)
- Vagus nerve stimulation in depression (2001) (47)
- Plasma GABA predicts acute response to divalproex in mania (1996) (47)
- Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication (2013) (46)
- Can state and trait variables be disentangled? A methodological framework for psychiatric disorders (1994) (46)
- Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. (2011) (46)
- Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity (2008) (46)
- Which endogenous depressive symptoms relate to REM latency reduction? (1986) (46)
- Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. (1983) (45)
- Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. (2001) (44)
- Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. (2008) (44)
- Impact of structured clinical interviews on physicians' practices in community mental health settings. (2003) (44)
- An Open Pilot Study of the Combination of Escitalopram and Bupropion-SR for Outpatients with Major Depressive Disorder (2008) (44)
- Depression in radiation oncology patients: a preliminary evaluation. (1998) (44)
- Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care. (2010) (44)
- A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children. (2007) (43)
- Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. (2008) (43)
- Critical issues in the treatment of affective disorders (1995) (43)
- What moderator characteristics are associated with better prognosis for depression? (2005) (43)
- Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project (2004) (43)
- Comparison of the delta EEG in the first and second non-REM periods in depressed adults and normal control (1992) (43)
- Sleep EEG findings in depressed children and adolescents. (1987) (43)
- Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients (2019) (42)
- Outcomes on the pharmacopsychometric triangle in bupropion‐SR vs. buspirone augmentation of citalopram in the STAR*D trial (2012) (42)
- National institute of mental health workshop report on the treatment of bipolar disorder (1996) (42)
- Low plasma gamma-aminobutyric acid levels in male patients with depression. (1992) (42)
- The efficacy of acute electroconvulsive therapy in atypical depression. (2008) (42)
- Health Impacts of Caregiving for Older Adults With Functional Limitations (2013) (42)
- Selecting methodologies for the evaluation of differences in time to response between antidepressants. (2002) (42)
- The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). (2019) (41)
- 2015 in Review. (2015) (41)
- Naltrexone in patients with bipolar disorder and alcohol dependence (2006) (41)
- Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression (1995) (41)
- Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data. (2007) (41)
- Neuropsychological dysfunctions in unipolar nonpsychotic major depressions. (1983) (41)
- Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression (2009) (41)
- REM latency concordance in depressed family members (1987) (41)
- Measuring use of outpatient care among mentally ill individuals: a comparison of self reports and provider records (1999) (41)
- The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder. (2008) (40)
- Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report (2012) (40)
- What predicts attrition in second step medication treatments for depression?: a STAR*D Report. (2009) (40)
- A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence. (2014) (40)
- Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. (2003) (39)
- Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study (2000) (39)
- Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics. (1983) (39)
- Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study. (1999) (39)
- Fluoxetine versus trazodone in the treatment of outpatients with major depression. (1988) (39)
- Clinical and Sociodemographic Characteristics Associated with Suicidal Ideation in Depressed Outpatients (2013) (39)
- Short-Term Psychotherapy of Depressive Disorders. (1994) (38)
- Does the pretreatment polysomnogram predict response to cognitive therapy in depressed outpatients? A preliminary report (1990) (38)
- Membrane biophysical studies of lymphocytes and erythrocytes in manic-depressive illness. (1982) (38)
- A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial (2018) (37)
- Screening for Major Depression in Private Practice (2009) (37)
- Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). (2014) (37)
- Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. (2007) (37)
- When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips. (2018) (37)
- Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department. (1999) (36)
- Effect of two prednisone exposures on mood and declarative memory (2006) (36)
- TRH-induced prolactin release is blunted in females with endogenous unipolar major depression (1984) (36)
- Acceptability of second-step treatments to depressed outpatients: A STAR*D report (2007) (35)
- Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS‐C16 and QIDS‐SR16) in the elderly (2010) (35)
- Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement (2018) (35)
- Toward a rational pharmacotherapy of depression. (1980) (35)
- The effect of dosage on the dexamethasone suppression test in normal controls (1982) (35)
- Comparison of Quality of Life Measures in a Depressed Population (2007) (35)
- Digital period analysis of EEG in depression: Periodicity, coherence, and interhemispheric relationships during sleep (1993) (35)
- Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome (1999) (35)
- Prospective assessment of electroencephalograpic sleep in remitted major depression (1993) (35)
- A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness. (2016) (35)
- Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP) (1999) (34)
- Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. (1982) (34)
- Measurement‐based care using DSM‐5 for opioid use disorder: can we make opioid medication treatment more effective? (2019) (34)
- Escitalopram in clinical practice: Results of an open‐label trial in a naturalistic setting (2005) (34)
- 16-item Quick Inventory of Depressive Symptomatology (2016) (34)
- Outcome measures of depression. (1997) (34)
- Oral contraceptives and depressive symptomatology: biologic mechanisms. (1979) (34)
- Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. (2002) (34)
- Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder (2012) (34)
- Toward a redefinition of psychiatric emergency. (2000) (33)
- Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients (1994) (33)
- Visual contrast sensitivity in major depressive disorder. (2013) (33)
- Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression. (2002) (33)
- What predicts attrition in second step medication treatments for depression? A STARD report (2008) (33)
- Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. (2013) (33)
- FROM SCIENTIFIC KNOWLEDGE TO THE CLINICAL PRACTICE OF PSYCHOPHARMACOLOGY :CAN THE GAP BE BRIDGED ? (1995) (33)
- Making clinicians lives easier: guidance on use of the QIDS self-report in place of the MADRS. (2006) (33)
- Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression (2020) (33)
- A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an Adult Outpatient Clinical Sample (2010) (33)
- Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial. (2016) (33)
- Problems associated with the diagnosis of depression. Discussion (1990) (32)
- Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity. (2019) (32)
- A comparison of alternative assessments of depressive symptom severity: a pilot study (2000) (32)
- Evidence for the segregation of a major gene for human plasma GABA levels (1999) (31)
- Improving Depression Outcome by Patient-Centered Medical Management. (2018) (31)
- The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative. (2000) (30)
- Adaptations of cognitive therapy for depressed adolescents. (1988) (30)
- Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate (2017) (30)
- Depression Treatment in Patients With General Medical Conditions: Results From the CO-MED Trial (2012) (30)
- Predictors of Attrition During One Year of Depression Treatment: A Roadmap to Personalized Intervention (2009) (30)
- Clinical and economic impact of newer versus older antipsychotic medications in a community mental health center. (1999) (30)
- Does pretreatment anxiety predict response to either bupropion SR or sertraline? (2001) (30)
- Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial (2008) (30)
- A cross-sectional study of the effects of depression on REM latency (1990) (30)
- Isn't It About Time to Employ Measurement-Based Care in Practice? (2015) (29)
- Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. (2011) (29)
- Characteristics of insured and noninsured outpatients with depression in STAR(*)D. (2005) (29)
- The impact of diabetes on depression treatment outcomes. (2010) (29)
- Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive Disorder (2018) (29)
- Regional cerebral blood flow alterations in unipolar depression (1993) (29)
- Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. (2008) (29)
- Personalizing antidepressant choice by sex, body mass index, and symptom profile: An iSPOT-D report (2017) (29)
- Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin. (2016) (29)
- VitalSign6: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression (2019) (28)
- Age-adjusted threshold values for reduced REM latency in unipolar depression using ROC analysis (1990) (28)
- Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR*D trial (2009) (28)
- Bupropion in the Treatment of Outpatients with Asthma and Major Depressive Disorder (2007) (28)
- Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder (2017) (28)
- Erratum: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (Proceedings of the National Academy of Sciences of the United States of America (November 25, 2003) 100, 24 (14293-14296)) (2005) (28)
- Catching up on health outcomes: the Texas Medication Algorithm Project. (2003) (28)
- Depression and Dexamethasone Suppression Testing in Children and Adolescents (1987) (27)
- Association Between Tea Consumption and Depressive Symptoms in Older Chinese Adults (2012) (27)
- Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). (2013) (27)
- A comparison of self-reported versus clinician-related symptoms in depression. (1987) (27)
- Sleep EEG in bulimic, depressed, and normal subjects (1989) (27)
- Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory (2010) (27)
- Which depressed patients respond to nefazodone and when? (2001) (27)
- Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. (2012) (27)
- Diurnal mood variation in outpatients with major depressive disorder (2009) (26)
- Combining antidepressant medications: a good idea? (2010) (26)
- A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project (2019) (26)
- A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder. (2015) (26)
- The effect of lithium on the membrane molecular dynamics of normal human erythrocytes (1987) (26)
- The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations. (2012) (26)
- Acylcarnitine Metabolomic Profiles Inform Clinically-Defined Major Depressive Phenotypes (2019) (25)
- Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes (2019) (25)
- Guidelines for the diagnosis and treatment of depression for primary care physicians. Implications for consultation-liaison psychiatrists. (1994) (25)
- Group versus individual cognitive therapy: A pilot study (2005) (25)
- Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder (2004) (25)
- Daily process methodology for measuring earlier antidepressant response. (2008) (25)
- Mental health care from the public perspective: the Texas Medication Algorithm Project. (1999) (24)
- Clinical practice guidelines for managing major depression in primary care practice: Implications for psychologists. (1994) (24)
- Identifying Risk for Attrition during Treatment for Depression (2009) (24)
- Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. (1989) (24)
- What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? (2012) (24)
- Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. (2016) (24)
- The Therapeutic Alliance and CBASP-Specific Skill Acquisition in the Treatment of Chronic Depression (2005) (23)
- Remission of maternal depression and child symptoms among single mothers (2007) (23)
- Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial. (2016) (23)
- Early Adverse Events and Attrition in Selective Serotonin Reuptake Inhibitor Treatment: A Suicide Assessment Methodology Study Report (2010) (23)
- Family history of depression and therapeutic outcome: findings from STAR*D. (2009) (23)
- Strategies and tactics in the management of maintenance treatment for depressed patients. (1999) (23)
- Ketamine for treatment-resistant depression: ready or not for clinical use? (2013) (23)
- Paroxetine for the treatment of premenstrual dysphoric disorder (1994) (23)
- Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale (2017) (23)
- Cognitive Response Test (1983) (23)
- Adherence to Antidepressant Combinations and Monotherapy for Major Depressive Disorder: A CO-MED Report of Measurement-Based Care (2014) (22)
- Clinician, Parent, and Child Prediction of Medication or Placebo in Double-Blind Depression Study (2000) (22)
- The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report. (2013) (22)
- Efficacy, safety, and indications for tricyclic and newer antidepressants (1994) (22)
- Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression (2019) (22)
- Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. (2018) (22)
- A psychometric evaluation of the clinician‐rated Quick Inventory of Depressive Symptomatology (QIDS‐C16) in patients with bipolar disorder (2009) (22)
- A Role for ΔFosB in Calorie Restriction-Induced Metabolic Changes (2011) (21)
- Secular trend in unipolar depression: a hypothesis. (1989) (21)
- Electronic source materials in clinical research: acceptability and validity of symptom self-rating in major depressive disorder. (2007) (21)
- Impulsivity and neuroendocrine response to buspirone in bulimia nervosa (1996) (21)
- Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet α2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity (1998) (20)
- The aims and design of the sequenced treatment alternatives to relieve depression (STAR*D) study (2005) (20)
- Problems associated with the diagnosis of depression. (1990) (20)
- A comparison of psychotic and nonpsychotic substance users in the psychiatric emergency room. (1998) (20)
- Adrenergic Receptor Function in Panic Disorder: I. Platelet α2 Receptors Gi Protein Coupling, Effects of Imipramine, and Relationship to Treatment Outcome (1999) (20)
- Effects of four normalizing methods on data analytic results in functional brain imaging (1996) (20)
- Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients (2016) (20)
- A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology. (2007) (20)
- Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders (2002) (20)
- Tricyclics and newer antidepressant medications: Treatment options for treatment‐resistant depressions (1994) (20)
- Quantitative EEG amplitude across REM sleep periods in depression: preliminary report. (2002) (20)
- Methodological issues in developing new acute treatments for patients with bipolar illness (2000) (20)
- Item response analysis of the inventory of depressive symptomatology (2006) (20)
- Toward an online cognitive and emotional battery to predict treatment remission in depression (2015) (20)
- Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. (1999) (19)
- Short-term psychotherapies for depression : behavioral, interpersonal, cognitive, and psychodynamic approaches (1982) (19)
- Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness (2018) (19)
- The effects of extended evaluation on depressive symptoms in children and adolescents. (1996) (19)
- Depression in primary care: detection, diagnosis, and treatment. Agency for Health Care Policy and Research. (1993) (19)
- Clinically Relevant Findings from STAR*D (2008) (19)
- Does learned resourcefulness predict response to cognitive therapy in depressed outpatients? (1991) (19)
- Implementation of the Texas Medication Algorithm Project patient and family education program. (2006) (19)
- A one year follow-up of the multimodal treatment for chronic pain (1982) (19)
- Effects of VNS on regional cerebral blood flow in depressed subjects (2002) (19)
- An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. (2006) (18)
- Neutrophil β2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls (1999) (18)
- Suppression of cortisol following dexamethasone in demented patients (1986) (18)
- Recommendations for depression publications. (1983) (18)
- Structured interview and uniform assessment improves diagnostic reliability. (2000) (18)
- Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders. (2001) (18)
- Can psychological features predict antidepressant response to rTMS? A Discovery–Replication approach (2019) (18)
- Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis (2019) (18)
- Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. (1993) (18)
- Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder (2017) (18)
- Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression (2020) (18)
- Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature (2020) (18)
- Overview of psychiatric disorders and the role of newer antidepressants. (2002) (18)
- Psychobiological predictors of antidepressant drug response. (1983) (18)
- Treatment algorithm use to optimize management of symptomatic patients with a history of mania. (1998) (17)
- Indicators of pretreatment suicidal ideation in adults with major depressive disorder (2009) (17)
- The Quick Inventory of Depressive Symptomatology (Clinician and Self-Report Versions) in Patients With Bipolar Disorder (2010) (17)
- The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. (2013) (17)
- Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants (2002) (17)
- The Relationship Between Adverse Events During Selective Serotonin Reuptake Inhibitor Treatment for Major Depressive Disorder and Nonremission in the Suicide Assessment Methodology Study (2011) (17)
- Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D report. (2015) (17)
- Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality. (2018) (17)
- The development of clinical paractice guidelines for the diagnosis and treatment of depression (1992) (17)
- Psychiatric emergency service use after implementation of managed care in a public mental health system. (2005) (17)
- Cognitive Therapy for Depressed Adolescents (1994) (17)
- From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? (1995) (17)
- Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report. (2015) (17)
- The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry (2020) (17)
- A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept. (2016) (17)
- The thyrotropin-releasing hormone stimulation test: A methodological study (1983) (16)
- Toward a very brief quality of life enjoyment and Satisfaction Questionnaire. (2019) (16)
- Changes in Depressive Symptoms and Social Functioning in the Sequenced Treatment Alternatives to Relieve Depression Study (2011) (16)
- A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. (2008) (16)
- Neutrophil beta(2)-adrenoceptor function in major depression: G(s) coupling, effects of imipramine and relationship to treatment outcome. (1999) (16)
- Sensitivity, specificity, and predictive power of the “Brief Risk-resilience Index for SCreening,” a brief pan-diagnostic web screen for emotional health (2012) (16)
- Recommendations for scientific reports on depression. (1983) (16)
- Vagus nerve stimulation (2001) (16)
- Enrolling research subjects from clinical practice: Ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial (2006) (16)
- Assessing anxious features in depressed outpatients (2011) (16)
- Cognitive therapy of depression: rationale, techniques, and efficacy. (1983) (16)
- Differences in psychiatric symptoms among Asian patients with depression: A multi‐country cross‐sectional study (2014) (16)
- Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report. (2015) (15)
- Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. (2007) (15)
- The use of placebos in unipolar major depression: the current status (2000) (15)
- EFFECT OF CONCURRENT SUBSTANCE USE DISORDER ON THE EFFECTIVENESS OF SINGLE AND COMBINATION ANTIDEPRESSANT MEDICATIONS FOR THE TREATMENT OF MAJOR DEPRESSION: AN EXPLORATORY ANALYSIS OF A SINGLE‐BLIND RANDOMIZED TRIAL (2012) (15)
- Conflict of interest-- an issue for every psychiatrist. (2009) (15)
- Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovation. (2007) (15)
- A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment. (2020) (15)
- Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. (2013) (15)
- Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population (2019) (14)
- Estimating optimal shared‐parameter dynamic regimens with application to a multistage depression clinical trial (2016) (14)
- Alprazolam in Bipolar‐I Depressions (1984) (14)
- Distinguishing functional from syndromal recovery: implications for clinical care and research. (2015) (14)
- Remission of maternal depression and child symptoms among single mothers (2007) (14)
- Childhood maltreatment and impact on clinical features of major depression in adults (2020) (14)
- The Edinburgh Postnatal Depression Scale as a measure for antenatal dysphoria (2015) (13)
- Clinical research challenges posed by difficult-to-treat depression (2022) (13)
- A practical approach to the early identification of antidepressant medication non-responders (2011) (13)
- Secondary depression: a comparison among subtypes. (1987) (13)
- 75 CURRENT AND EMERGING THERAPEUTICS FOR DEPRESSION (2002) (13)
- Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers. (2020) (13)
- The Impact of Nonclinical Factors on Care Use for Patients with Depression: A STAR*D Report (2009) (13)
- A comparison of alternative assessments of depressive symptom severity: a pilot study (2000) (13)
- EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial (2021) (13)
- Can a Framework Be Established for the Safe Use of Ketamine? (2018) (12)
- Measuring Use and Cost of Care for Patients With Mood Disorders: The Utilization and Cost Inventory (2009) (12)
- A Clinician's Perspective on Biomarkers. (2018) (12)
- Growth hormone response to baclofen: a comparison of 10-mg and 20-mg doses in healthy men (1996) (12)
- The role of efficacy and effectiveness trials (2009) (12)
- Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. (2008) (12)
- Gender Differences in Depression Symptoms in Treatment-Seeking Adults: STAR*D Confirmatory Analyses (2008) (12)
- Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report (2021) (12)
- Depression : basic mechanisms, diagnosis, and treatment (1986) (12)
- Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. (1989) (12)
- Metabolomic and inflammatory signatures of symptom dimensions in major depression (2021) (12)
- Effectiveness Study of Venlafaxine-XR Combined with Aripiprazole for Chronic or Recurrent Major Depressive Disorder (2009) (12)
- Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder (2003) (12)
- Effect of structured interviews on evaluation time in pediatric community mental health settings. (2005) (12)
- Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder (2019) (11)
- Strategies for Implementing Psychiatric Medication Algorithms in the Public Sector (1999) (11)
- New designs for studies of the prophylaxis of bipolar disorder. (2002) (11)
- Clinical practice guidelines for managing major depression in primary care practice. Implications for psychologists. U.S. Public Health Service Agency for Health Care Policy and Research. (1994) (11)
- 530. The influence of age on the response of major depression to electroconvulsive therapy (2000) (11)
- Single-photon tomographic determination of regional cerebral blood flow in psychiatric disorders (1984) (11)
- A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio. (2003) (11)
- Factors Associated with Concomitant Psychotropic Drug Use in the Treatment of Major Depression: A STAR*D Report (2009) (11)
- Does pretreatment insomnia or anxiety predict acute response to bupropion SR? (2005) (11)
- Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women. (2015) (11)
- Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses (2021) (11)
- Speculations on the Future of Psychiatric Diagnosis (2018) (11)
- Neutrophil beta2-adrenergic receptor coupling efficiency to Gs protein in subjects with post-traumatic stress disorder and normal controls. (1999) (11)
- 77-2 A double-blind placebo controlled trial of fluoxetine in depressed children and adolescents (1997) (11)
- Pretreatment Correlates of the Therapeutic Alliance in the Chronically Depressed (2002) (11)
- Establishing Priorities in Treatment (2000) (11)
- Characteristics of norepinephrine and clonidine displacement of [3H]yohimbine binding to platelet alpha2-adrenoreceptors in healthy volunteers (1999) (10)
- Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial (2018) (10)
- Clinical Implications of the STAR*D Trial. (2019) (10)
- The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients (2019) (10)
- Screening for postnatal depression in Chinese‐speaking women using the Hong Kong translated version of the Edinburgh Postnatal Depression Scale (2013) (10)
- A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder. (2018) (10)
- Depression spectrum disease with and without depression in first-degree relatives. (1995) (10)
- Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. (2004) (10)
- Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings (2021) (9)
- A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression (2009) (9)
- Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis. (2016) (9)
- Data-driven longitudinal modeling and prediction of symptom dynamics in major depressive disorder: Integrating factor graphs and learning methods (2017) (9)
- Low plasma γ-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder (1996) (9)
- Medication optimization during clozapine treatment. (1996) (9)
- It Is Time to Take a Stand for Medical Research and Against Terrorism Targeting Medical Scientists (2008) (9)
- Melancholia and response to ECT. (1995) (8)
- Variable and threshold selection to control predictive accuracy in logistic regression (2014) (8)
- A Report of Trazodone‐Associated Laboratory Abnormalities (1990) (8)
- Differentiating primary affective disease, organic affective syndromes, and situational depression on a pediatric service. (1983) (8)
- Naturalistic study of the early psychiatric use of citalopram in the United States (2002) (8)
- Narrowing the gaps between what we know and what we do in psychiatry. (2015) (8)
- Insured and non-insured depressed outpatients: how do they compare? (2007) (8)
- Mood disorders : systematic medication management (1997) (8)
- Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report (2021) (8)
- Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR). (2020) (8)
- Chronic Major Depression: A Review and Update (2001) (8)
- Serum concentrations of deoxycorticosterone in women during the luteal phase of the ovarian cycle are not suppressed by dexamethasone treatment. (1983) (7)
- Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study (2020) (7)
- Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project (2003) (7)
- Cognitive Therapy for Panic Disorder and Generalized Anxiety Disorder (1988) (7)
- Practice Guidelines in Mental Health and Addiction Services: Contributions from the American College of Mental Health Administration (2002) (7)
- Screening for panic-related anxiety in emergency department patients with cardiopulmonary complaints: A comparison of two self-report instruments (2018) (7)
- What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study. (2020) (7)
- 358. Serial discontinuation of SSRI treatment for PMDD (1998) (7)
- Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment (2019) (7)
- Depressive disorders: treatment patterns and costs of treatment in the private sector of the United States (1995) (7)
- Functional Indices of Biological Disturbance (1983) (7)
- Toward a very brief self‐report to assess the core symptoms of depression (VQIDS‐SR5) (2017) (7)
- Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. (1997) (7)
- The Treatment of Emotional Disorders (1982) (7)
- Platelet α2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls (1999) (7)
- The Concise Health Risk Tracking Self‐Report (CHRT‐SR) assessment of suicidality in depressed outpatients: A psychometric evaluation (2018) (6)
- Setting Measurement-Based Care in Motion: Practical Lessons in the Implementation and Integration of Measurement-Based Care in Psychiatry Clinical Practice (2021) (6)
- Quality improvement methods as applied to a multicenter effectiveness trial--STAR*D. (2005) (6)
- A Brief Interview to Detect Panic Attacks and Panic Disorder in Emergency Department Patients with Cardiopulmonary Complaints (2018) (6)
- A Review of Vagus Nerve Stimulation for Treatment-Resistant Depression (2001) (6)
- Depression: Must pharmacotherapy fail for cognitive therapy to succeed? (1978) (6)
- An open, multisite pilot study of cognitive therapy for depressed adolescents. (1995) (6)
- Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records (2021) (6)
- Validation of the Inventory of Depressive Symptomatology (IDS) in Cocaine Dependent Inmates (2001) (6)
- Clinical use of nefazodone in major depression: a 6-year perspective. (2002) (6)
- An empirical analysis of cost outcomes of the Texas Medication Algorithm Project (2006) (6)
- Developing the evidence for evidence-based practice (2008) (6)
- Effects of heart disease on depression treatment: results from the COMED study. (2012) (6)
- The development of clinical practice guidelines for the diagnosis and treatment of depression. (1992) (6)
- The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders (2020) (6)
- Vagus nerve stimulation: clinical results in depression (2002) (6)
- Recommendations for depression publications (1983) (6)
- The Implementation of Cognitive Therapy in STAR*D (2004) (6)
- Developing the evidence for evidence-based practice. (2008) (6)
- Cognitive therapy of depression: Utilizing the couples system (1980) (6)
- Tools to facilitate the teaching and enhance the practice of psychopharmacology. (2016) (5)
- Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment (2019) (5)
- At the Research Front*: Cognitive Therapy for Depression (1979) (5)
- Treatment and Prevention of Depression in Women. (2006) (5)
- The Adolescent Resilience Questionnaire: Validation of a Shortened Version in U.S. Youths (2020) (5)
- Polysomnogram in major depressive and obsessive-compulsive disorders: A preliminary study (1994) (5)
- The effectiveness of antidepressant monotherapy in a naturalistic outpatient setting. (2012) (5)
- The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder (2018) (5)
- Measuring medical offsets of psychotherapy. (1999) (5)
- Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes (2016) (5)
- Recommendations for Depression Publications (1983) (5)
- Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure. (2019) (5)
- Association between depression and hypertension using classic and revised blood pressure thresholds. (2020) (5)
- Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example (2020) (5)
- Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline. (1988) (5)
- Clinical Implications of the STAR*D Trial. (2019) (4)
- Reconceptualising treatment-resistant depression as difficult-to-treat depression. (2021) (4)
- Engaging Depressed Patients: An Essential Step in Optimizing Care. (2017) (4)
- Erratum: Remission of maternal depression and child symptoms among single mothers - A STAR*-child report (Social Psychiatry and Psychiatric Epidemiology (2007) vol. 42 (12) (962-971) 10.1007/s00127-007-0262-4) (2007) (4)
- Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression. (2021) (4)
- Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression (2008) (4)
- Treatment Evaluation and Behavior Therapy (1982) (4)
- The inventory of depressive symptomatology (IDS): validityand reliability of clinician (IDS-C30) and self-report form(IDS-SR30) in patients with major depressive disorder - (2006) (4)
- Higher beta adrenoreceptor density and supercoupling to GS protein in panic disorder (1994) (4)
- When do patients respond to tricyclic antidepressants? (1994) (4)
- Psychoanalytic and cognitive therapies: a comparison of theory and tactics. (1984) (4)
- Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials (2019) (4)
- Natural Language Processing-Based Quantification of the Mental State of Psychiatric Patients (2020) (4)
- Psychotherapy of the affective psychoses (1980) (4)
- Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia (2002) (4)
- Clinical diagnosis of mood disorders. (1988) (4)
- on Medication Treatment of Childhood Major Depressive Disorder (1999) (4)
- Targeting treatments for depression: what can our patients tell us? (2016) (4)
- Cognitive-Behavioral Therapy for Bipolar Disorder, Second Edition (2005) (3)
- Plasma GABA predicts response to divalproex in mania (1995) (3)
- Arecoline reverses dexamethasone suppression of cortisol in normal males: A pilot study (1995) (3)
- [Vagus nerve stimulation. A potential therapy for chronic/recurrent depression?]. (2002) (3)
- Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. (1982) (3)
- 90-28 Maintenance therapy of chronic depression: A placebo-controlled trial of sertraline (1997) (3)
- The Concise Health Risk Tracking - Self-Report (CHRT-SR)-A measure of suicidal risk: Performance in adolescent outpatients. (2022) (3)
- Computerizing the Texas Medication Algorithm Project. (1999) (3)
- Antidepressant selection: Focus on nefazodone (2002) (3)
- Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach (2017) (3)
- Point : the top 10 reasons for psychopharmacology supervision. (1996) (3)
- Voice response system to measure healthcare costs: a STAR*D report. (2009) (3)
- Anxiolysis associated with antidepressant response to bupropion sustained release or sertraline (2000) (3)
- Measurement-based care for the treatment of depression (2009) (2)
- The Effects of Fluoxetine on Quantitative Sleep EEG in Depressed Outpatients (2000) (2)
- Research and the practice of psychotherapy. (1996) (2)
- Mood & anxiety disorders (1997) (2)
- How Are Attention-deficit Hyperactivity and Internet Gaming Disorders Related in Children and Youth? (2021) (2)
- Effects of antidepressants on sleep: Focus on nefazodone (2002) (2)
- A comparison of the cortisol suppression index and the dexamethasone suppression test. (1984) (2)
- Cognitive Therapy Augmentation versus CT Switch Treatment: A STAR*D Report (2009) (2)
- Personal Assessment: Research and clinical practice: bridging the gap (1994) (2)
- Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. (2022) (2)
- Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders (2009) (2)
- Peripheral GABA levels in patients with premenstrual dysphoric disorder (1995) (2)
- Do depressed patients with diabetes experience more side effects when treated with CitalopramThan their counterparts without diabetes? a STAR*D study. (2009) (2)
- PMH49 INTERNATIONAL INVESTIGATION INTO DEPRESSION BASED ON THE STRUCTURED INTERVIEW GUIDE FOR THE HAMILTON DEPRESSION RATING SCALE (SIGH-D) AND THE CLINICIAN RATED INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY (IDS-C) (2008) (2)
- Release bias in accessing medical records in clinical trials: a STAR*D report (2009) (2)
- Secondary agoraphobia: two case reports. (1984) (2)
- Economic aspects of nefazodone, CBASP, and their combination for the treatment of chronic depression (2000) (2)
- Recommendations for depression publications To the editor: (1983) (2)
- Effects of amphetamine in major depressive disorder using functional MRI (1995) (2)
- Making Therapy Widely Available: Clinical Research Triumph or Existential Catastrophe? (2022) (2)
- Interpersonal Psychotherapy of Depression (1985) (2)
- Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression (2021) (2)
- RECURRENT BRIEF DEPRESSION: A DSM‐IV PERSPECTIVE (1992) (2)
- Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy: A Series of 10 Cases. (2020) (2)
- and Carbamazepine in Children and Adolescents With Bipolar Disorder (2000) (2)
- P.1.185 Does pretreatment anxiety or insomnia predict acute response to bupropion SR? (2003) (2)
- Clinical and neurophysiological predictors of rTMS response in Major Depressive Disorder: Robustness and clinical relevance (2019) (1)
- Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder. (2020) (1)
- Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP) (2008) (1)
- Alpha-2 adrenoreceptor density and coupling to Gi protein in PTSD (1994) (1)
- Vagus Nerve Stimulation for Treatment-ResistantDepression: A Randomized, Controlled AcutePhase Trial (2005) (1)
- Data driven clusters derived from resting state functional connectivity: Findings from the EMBARC study. (2022) (1)
- Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research? (2017) (1)
- Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder: A Case Report. (2020) (1)
- Anterior cingulate cortex in individuals with depressive symptoms: A structural MRI study (2021) (1)
- Mental health care from the public perspective : The Texas Medication Algorithm Project. Discussion (1999) (1)
- Biomarkers: Where Are We Going? (2018) (1)
- Alpha-2 adrenoreceptor coupling in panic disorder: Effect of imipramine (1994) (1)
- Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population (2021) (1)
- Recommendations for depression publications. (1983) (1)
- Introduction: Management of Treatment-Resistant Depression (2001) (1)
- Fluoxetine decreased depressive symptoms in children and adolescents with nonpsychotic major depressive disorder (1998) (1)
- Effects of vagus nerve stimulation on sleep in depressed patients (2002) (1)
- Inventory of Depressive Symptomatology–-Self-Report--30-item Version (2014) (1)
- Placebo Responsiveness Does Not Imply that Placebo Is a Sufficient Treatment (1994) (1)
- S-26-3 Gender differences in the response to pharmacotherapy among early onset dysthymics (1996) (1)
- DISPUTING PSYCHIATRY'S REDEFINITION. AUTHORS' REPLY (1997) (1)
- Improving Depression Outcome by Patient-Centered Medical Management. (2020) (1)
- Dynamic single photon emission computerized tomography in patients with obsessive-compulsive disorder (1989) (1)
- Adrenergic receptor function in premenstrual dysphoric disorder (1995) (1)
- P-2-72 Comparison of the effects of nefazodone and fluoxetine on sleep architecture and sleep efficiency in depressed patients (1995) (1)
- 430. Sex differences in the response to pharmacotherapy among early onset dysthymics (1996) (1)
- Blue Dreams: The Science and the Story of the Drugs That Changed Our Mindsby Lauren Slater. New York, Little, Brown, 2018, 416 pp., $28.00 (hardcover). (2018) (1)
- Remission of Maternal Depression and Children’s Psychopathology—Reply (2006) (1)
- Psychometric and Clinical Evaluation of the Clinician (VQIDS-C5) and Self-Report (VQIDS-SR5) Versions of the Very Quick Inventory of Depressive Symptoms (2022) (1)
- Beta-adrenoreceptor density and coupling to GS protein in PTSD (1994) (1)
- Clinical Characteristics of Placebo Response in Depression (1989) (1)
- Serotonin mechanisms in learned helplessness, depression, and obsessive-compulsive disorder (1989) (1)
- Alprazolam in bipolar‐1 depressions (1984) (1)
- STAR*D Clarification (2006) (1)
- Platelet alpha2-adrenergic receptor coupling efficiency to Gi protein in subjects with post-traumatic stress disorder and normal controls. (1999) (1)
- Are biological abnormalities related to prior course of depressive illness? (1989) (1)
- Medical test development and implementation: a multistep journey. (2015) (1)
- Reply to Self-Medication, Bipolar Disorders, and Stimulant Dependence (2009) (1)
- PowerPoint Slides for: Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes (2016) (0)
- Mood Disorders (Preliminary Pages) (1997) (0)
- Does learned resourcefulness predict response therapy in depressed outpatients (1991) (0)
- Digital period analysis (DPA) of EEG in schizophrenia (SZ): Periodicity, coherence and interhemispheric relationships during sleep (1993) (0)
- Recent Advances in the Management of Major Depression: An Evidence-Based Approach (2007) (0)
- Disclosure of Editors' Financial Relationships. (2016) (0)
- Response to Blier letter (2012) (0)
- Dr. Trivedi and Colleagues Reply (2006) (0)
- Plasma serotonin, comorbidity, family history, and the relationship of obsessive-compulsive disorder to major depressive disorder (1989) (0)
- Behavioral / Systems / Cognitive Antidepressant Actions of Histone Deacetylase Inhibitors (2009) (0)
- Reply (2002) (0)
- BIOLOGICAL AND COGNITIVE PREDICTORS OF RESPONSE TO ACUTE TREATMENT IN DEPRESSED OUTPATIENTS (1992) (0)
- Brief Bipolar Disorder Symptom Scale (2015) (0)
- A timely investment: coordinated care for depression and anxiety disorders. (2011) (0)
- Maintaining a Steady Course One of the “Hottest Journals of the Millennium…” (2005) (0)
- Artificial-intelligence-augmented psychiatry with pharmacogenomics: towards individualization of antidepressant selection in patients with major depressive disorder (2019) (0)
- A Descriptive Analysis of Minor Depression (2005) (0)
- Bipolar Disorder and Crossover Design: Reply to Curtin Letter (2003) (0)
- Preliminary study of ketoconazole in bipolar disorder (2000) (0)
- Integrating Psychologic and Biologic Bases for Depression. (1986) (0)
- Autonomic activity in panic disorder and PTSD (1995) (0)
- 6. An update on new somatic treatments for depression—ECT, TMS, VNS, DBS (2000) (0)
- How objective is medical practice? (1998) (0)
- Reply (2006) (0)
- [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?]. (1986) (0)
- Experimental therapeutics and biological psychiatry (2005) (0)
- Preliminary communication Acupuncture: a promising treatment for depression during pregnancy (2004) (0)
- T163. Chronic Vagus Nerve Stimulation Significantly and Uniquely Improves Quality of Life in Treatment-Resistant Major Depression (2018) (0)
- Psychometric Evaluation of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in a General Youth Population (2021) (0)
- Toward precision medicine for depression: admitting ignorance and focusing on failures (2016) (0)
- Low plasma GABA is a stable trait marker of mood disorders (1994) (0)
- O-48 - the International Study to Predict Optimized Treatment - in Depression: Rational, Design and Initial Findings (2012) (0)
- Toward precision medicine for depression: admitting ignorance and focusing on failures. (2016) (0)
- Subject Index Vol. 78, 2009 (2009) (0)
- The Diffi culty of Making a Sole Diagnosis of Anti social Personality Disorder (2010) (0)
- Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life. (2023) (0)
- The Clinical Neuropsychiatry of Stroke: Cognitive, Behavioral and Emotional Disorders Following Vascular Brain Injury (1999) (0)
- Updating descriptive diagnosis. (1980) (0)
- Electrical Stimulation Techniques (2005) (0)
- 147. A Prospective, Multi-Center, Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Depression: The Recover Trial Baseline Data (2023) (0)
- A Prospective, Multi-center Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Depression: the RECOVER Trial (2023) (0)
- Vaccine-Induced Psychosis as an Etiology to Consider in the Age of COVID-19. (2022) (0)
- DEPRESSION GAYNES AND COLLEAGUES (0)
- NDT_A_308615 1621..1631 (2021) (0)
- HHV-6 and Schizophrenia (2022) (0)
- Disclosure of Editors' Financial Relationships. (2018) (0)
- Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study (2022) (0)
- Two Cases Comparing the Presentations and Outcomes of Heroin-induced Toxic Leukoencephalopathy. (2022) (0)
- Treatment-resistant High Output Ileostomy Secondary to Subtherapeutic Valproic Acid. (2021) (0)
- Response to commentaries. (2019) (0)
- Major depressive disorder: similar remission rates with bupropion, sertraline, or venlafaxine following treatment switch from (2006) (0)
- Life Engagement Improvement Following Initiation of Brexpiprazole Treatment in Patients with MDD: A Naturalistic, Retrospective Real-World Study (2023) (0)
- The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk: Performance in adult primary care patients (2023) (0)
- Antecedentes familiares de suicidio consumado y características del trastorno depresivo mayor: Estudio STAR*D (sequenced treatment alternatives to relieve depression) (2008) (0)
- The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation (2023) (0)
- The authors reply [4] (2006) (0)
- Response (1987) (0)
- Clinical predictors of cognitive function change in schizophrenia (2003) (0)
- AssociationBetweenMajorDepressiveEpisodes in Patients With Chronic Kidney Disease andInitiationofDialysis,Hospitalization,orDeath (2013) (0)
- Concise Health Risk Tracking Scale (2020) (0)
- NDT_A_305331 2333..2345 (2021) (0)
- Exploratory Analysis of Practical Trial Data for Informing the Individualization Of Treatment (2009) (0)
- T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment (2019) (0)
- Treatment-Resistant Mood Disorders (2003) (0)
- Anticipated Benefits of Care Questionnaire (2014) (0)
- Academic Highlights: Ongoing Needs in Depression (1996) (0)
- 3. Sequencing and combining treatments: can the art become a science? (2000) (0)
- Dr. Scheffer and Colleagues Reply (2005) (0)
- Ethnic/racial comparisons in symptomatology in a large sample of patients with schizophrenia in Texas (2003) (0)
- Drs. Lieberman and Rush Reply (1997) (0)
- Reply (2005) (0)
- Predicting response to cognitive therapy in depressed outpatients using sleep polysomnography: A preliminary report (1989) (0)
- Quick Inventory of Depressive Symptomatology--Self Report Version (2017) (0)
- Cross-Validation of A 7-Item Clinical Decision Rule for Detecting Panic-Related Anxiety in Emergency Medicine Patients (2016) (0)
- In Memoriam: Jan Fawcett, MD, 1934-2022. (2022) (0)
- The Effects of N efazodone on Slee p Architecture in Depression (1994) (0)
- and Caregiving Limitations : Results From the Singapore Survey on Informal Health Impacts of Caregiving for Older Adults With Functional (2013) (0)
- Sensitivity, specificity and predictive power of the "BRISC", a cross-sectional study on a brief web screen for brain health (2011) (0)
- Dr. McGrath and Colleagues Reply (2007) (0)
- P.2.c.035 Research update from the latest STAR*D findings (2006) (0)
- Toward a Definition of "No Meaningful Benefit" From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales. (2022) (0)
- Recommendations for depression publications. (1983) (0)
- GABA neuroendocrine challenge in normal controls (1995) (0)
- What are the new treatments for bipolar disorder? (1998) (0)
- Reply to El-Mallakh et al. Letter (2010) (0)
- Over-Optimism of Cognitive Behavior Therapy for Schizophrenia (2006) (0)
- Over-Optimism of Cognitive Behavior Therapy for Schizophrenia (2006) (0)
- The frequency of remission, relapse and recurrence in children and adolescents with MDD (1995) (0)
- Prediction of Non-Remission to Anti-Depressant Therapy Using Diffusion Tensor Imaging Running Title : Predicting Depression Nonremission with DTI (2016) (0)
- Management of Treatment-Resistant Depression (2001) (0)
- O-17-6 Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder (1996) (0)
- Effectiveness Trials in Mood Disorders (2000) (0)
- Response (1986) (0)
- Management Challenges of Recurrent Foreign Body Ingestions in a Psychiatric Patient: A Case Report. (2023) (0)
- Bibliography B IPOLAR D ISORDER (2011) (0)
- Medication algorithms for schizophrenia (1998) (0)
- In reply [11] (2006) (0)
- 118. Ketanserin binding characteristics to 5-HT2A receptor: Evidence for two binding subsites (1996) (0)
- ClinicalDiagnosis of Mood Disorders (1988) (0)
- Pretreatment anxiety does not predict response to bupropion sustained release or sertraline (1999) (0)
- Special Issue on Therapeutics (2006) (0)
- Reply to Possible Bipolar Nature of Irritability in Major Depressive Disorder (2005) (0)
- 325. Serotonin displacement of 3H-ketanserin binding to platelet 5-HT2A receptors in normal controls and depressed patients (1998) (0)
- Plasma delta sleep inducing peptide (DSIP) is elevated in symptomatic depressed and remitted depressed patients (1989) (0)
- Mini Quality of Life Enjoyment and Satisfaction Questionnaire (2019) (0)
- 184. Tryptophan depletion in premenstrual dysphoric disorder (1998) (0)
- Can the digital revolution improve care for mood disorders patients? (2021) (0)
- Treatment selection in major depression. (1992) (0)
- Introduction: Chronic Major Depression: A Review and Update (2001) (0)
- T136. Anterior Cingulate Cortex and Depressive Symptoms: A Structural MRI Study (2018) (0)
- 108. rCBF changes with clozapine treatment in refractory bipolar disorder (1996) (0)
- 285. Effects of hydrocortisone on β-adrenoceptor coupling to GS protein in depression before and after treatment (2000) (0)
- Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR9) (a measure of suicidal risk) in adolescent psychiatric outpatients. (2023) (0)
- PMH12 Texas Medication Algorithm Project: Feasibility Study of Implementing Medication Algorithms in the Public Mental Health Sector (1998) (0)
- The STAR*D Citalopram data revisited with the HAM-D6 and IDS-C6 (2013) (0)
- Temporal multi-step predictive modeling of remission in major depressive disorder using early stage treatment data; STAR*D based machine learning approach. (2022) (0)
- Alpha-2 and Beta-2 Adrenoreceptor Coupling To Adenylate Cyclase in Panic Disorder: Effect of Imipramine Treatment (1994) (0)
- 533. The effects of clozapine on sleep EEG in bipolar illness (1996) (0)
- Lead research report Gender differences in depression: Findings from the STAR*D study B (2005) (0)
- Research and the practice of psychotherapy. (1996) (0)
- 423. Comparative effects of nefazodone & fluoxetine on sleep in outpatients with major depressive disorder (1996) (0)
- Implementing guidelines and systems of care (1999) (0)
- Contents Vol. 78, 2009 (2009) (0)
- Comments on Special Drug Abuse Issue (1972) (0)
- Supplementary Material for: Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes (2016) (0)
- 36. Inflammatory Biomarkers as Viable Moderators of Selecting between SSRI and Bupropion in Depressed Outpatients (2017) (0)
- S107. Identifying Characteristics of Placebo Responders in Major Depression From the EMBARC Study (2018) (0)
- Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors (2009) (0)
- Biological psychiatry: Looking ahead (1997) (0)
- Dr. Rush Replies. (2008) (0)
- Introduction: Recognizing Treatment-Resistant Depression (2001) (0)
- Drs. Kupfer and Rush Reply (1984) (0)
- A 60-year-old Man with Major Depression (2007) (0)
- Feasibility trial of the schizophrenia algorithm in TMAP (2000) (0)
This paper list is powered by the following services:
Other Resources About Augustus John Rush
What Schools Are Affiliated With Augustus John Rush?
Augustus John Rush is affiliated with the following schools:
